FLASH NEWS LIVE

Aclarion secures $10.4M for back-pain diagnostic technology

Aclarion secures $10.4M for back-pain diagnostic technology

Aclarion Inc. (Nasdaq: ACON) recently raised $10.4 million through a stock sale, funding that extends the Broomfield-based health-care technology company’s operating runway into 2028, as it works to expand insurance coverage for its advanced imaging decision support tool for chronic back pain.

Read Full Article →

📱 Tip: Tap the 🔗 Share icon in Safari and choose Add to Home Screen to install World Trade Factory.
Instagram Meta X LinkedIn Whatsapp